RNA processing pathways in amyotrophic lateral sclerosis.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 20349096)

Published in Neurogenetics on March 27, 2010

Authors

Marka van Blitterswijk1, John E Landers

Author Affiliations

1: Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA.

Articles citing this

Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet (2010) 2.75

The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. J Clin Invest (2011) 1.62

Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions. Sci Rep (2012) 1.58

TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells. J Biol Chem (2012) 1.50

Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat Chem Biol (2014) 1.43

ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules. Hum Mol Genet (2013) 1.20

Cellular model of TAR DNA-binding protein 43 (TDP-43) aggregation based on its C-terminal Gln/Asn-rich region. J Biol Chem (2012) 1.08

Proteostasis and movement disorders: Parkinson's disease and amyotrophic lateral sclerosis. Cold Spring Harb Perspect Biol (2011) 1.02

Cerebrovascular disorders: molecular insights and therapeutic opportunities. Nat Neurosci (2011) 1.01

Functions of FUS/TLS from DNA repair to stress response: implications for ALS. ASN Neuro (2014) 0.95

Can transcriptomics cut the gordian knot of amyotrophic lateral sclerosis? Curr Genomics (2011) 0.94

Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice. J Neuropathol Exp Neurol (2012) 0.94

Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D(2) concept. Expert Rev Proteomics (2010) 0.93

Amyotrophic lateral sclerosis: update and new developments. Degener Neurol Neuromuscul Dis (2012) 0.91

Profilin-1 mutations are rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.90

Characterization of FUS mutations in amyotrophic lateral sclerosis using RNA-Seq. PLoS One (2013) 0.87

Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stress. Angiogenesis (2012) 0.85

Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene. Mol Neurodegener (2014) 0.84

Exploring new pathways of neurodegeneration in ALS: the role of mitochondria quality control. Brain Res (2014) 0.84

Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1. Hum Mol Genet (2014) 0.80

Aberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets? Neurodegener Dis Manag (2014) 0.78

ALS mutations in TLS/FUS disrupt target gene expression. Genes Dev (2015) 0.78

TDP-43 suppresses tau expression via promoting its mRNA instability. Nucleic Acids Res (2017) 0.78

A network of RNA and protein interactions in Fronto Temporal Dementia. Front Mol Neurosci (2015) 0.77

Altered RNA metabolism and amyotrophic lateral sclerosis. Ann Indian Acad Neurol (2011) 0.76

Articles cited by this

(truncated to the top 100)

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (2006) 27.96

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature (1993) 21.65

Identification and characterization of a spinal muscular atrophy-determining gene. Cell (1995) 17.41

TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science (2008) 14.09

Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science (2009) 13.45

Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science (2009) 12.99

TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet (2008) 9.51

A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A (1999) 7.60

Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature (2008) 7.18

Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. Neuron (2004) 6.71

Movement of eukaryotic mRNAs between polysomes and cytoplasmic processing bodies. Science (2005) 6.26

TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol (2007) 5.98

RecQ helicases: caretakers of the genome. Nat Rev Cancer (2003) 5.83

TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol (2008) 5.58

TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol (2008) 5.33

Mutant dynactin in motor neuron disease. Nat Genet (2003) 5.28

hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol (1999) 5.27

Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J (2001) 5.23

Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol (1995) 5.18

A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet (1999) 5.09

The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet (1997) 4.86

A novel nuclear structure containing the survival of motor neurons protein. EMBO J (1996) 4.72

DExD/H box RNA helicases: from generic motors to specific dissociation functions. Mol Cell (2001) 4.72

Rethinking ALS: the FUS about TDP-43. Cell (2009) 4.71

SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell (2008) 4.54

Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet (1993) 4.12

Angiogenin cleaves tRNA and promotes stress-induced translational repression. J Cell Biol (2009) 4.07

TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem (2005) 3.99

ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet (2006) 3.88

Separable roles for rent1/hUpf1 in altered splicing and decay of nonsense transcripts. Science (2002) 3.84

Elongator controls the migration and differentiation of cortical neurons through acetylation of alpha-tubulin. Cell (2009) 3.80

DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet (2004) 3.72

Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet (2008) 3.66

Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol (2007) 3.55

Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J Neurosci (2007) 3.52

SMN oligomerization defect correlates with spinal muscular atrophy severity. Nat Genet (1998) 3.51

Genome-wide distribution of yeast RNA polymerase II and its control by Sen1 helicase. Mol Cell (2006) 3.46

Neuronal RNA granules: movers and makers. Neuron (2006) 3.44

TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem (2009) 3.29

Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum Mol Genet (2007) 3.09

Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron (2002) 3.08

Axonal transport and neurodegenerative disease. Biochim Biophys Acta (2006) 3.06

An early step in wobble uridine tRNA modification requires the Elongator complex. RNA (2005) 3.01

TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. J Neurochem (2007) 2.91

Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum Mol Genet (2008) 2.82

Structural determinants of the cellular localization and shuttling of TDP-43. J Cell Sci (2008) 2.79

TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol Cell Neurosci (2007) 2.75

Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat Genet (2004) 2.75

Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci (2010) 2.73

Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs. PLoS One (2007) 2.70

Familial dysautonomia is caused by mutations of the IKAP gene. Am J Hum Genet (2001) 2.67

The granulin gene family: from cancer to dementia. Bioessays (2009) 2.67

Stress induces tRNA cleavage by angiogenin in mammalian cells. FEBS Lett (2008) 2.66

Evidence for distinct mechanisms facilitating transcript elongation through chromatin in vivo. EMBO J (2004) 2.63

Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet (2008) 2.48

hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J (1996) 2.42

Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum Mol Genet (2009) 2.40

Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res (2007) 2.38

Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res (2009) 2.37

TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J Cell Sci (1997) 2.35

TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol (2009) 2.30

The survival of motor neurons (SMN) protein interacts with the snoRNP proteins fibrillarin and GAR1. Curr Biol (2001) 2.29

A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev (1994) 2.29

TLS, EWS and TAF15: a model for transcriptional integration of gene expression. Brief Funct Genomic Proteomic (2006) 2.29

Elongator is a histone H3 and H4 acetyltransferase important for normal histone acetylation levels in vivo. Proc Natl Acad Sci U S A (2002) 2.27

The interaction between cytoplasmic dynein and dynactin is required for fast axonal transport. Proc Natl Acad Sci U S A (1997) 2.26

TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain (2007) 2.25

Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum Mol Genet (2009) 2.23

Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J Biol Chem (1998) 2.21

Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol (2009) 2.20

Genotyping pooled DNA on microarrays: a systematic genome screen of thousands of SNPs in large samples to detect QTLs for complex traits. Behav Genet (2004) 2.14

Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology (2004) 2.14

Identification of an RNA binding specificity for the potential splicing factor TLS. J Biol Chem (2000) 2.10

Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. Biochem Biophys Res Commun (1995) 2.06

High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis. Hum Mutat (2009) 2.05

Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons? Hum Mol Genet (2002) 2.05

The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol (2008) 2.04

Coilin forms the bridge between Cajal bodies and SMN, the spinal muscular atrophy protein. Genes Dev (2001) 2.03

Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2009) 2.03

Myosin-Va facilitates the accumulation of mRNA/protein complex in dendritic spines. Curr Biol (2006) 2.02

Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet (2001) 2.00

Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis. J Med Genet (2008) 2.00

Genetics of familial amyotrophic lateral sclerosis. Neurology (2008) 2.00

Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc Natl Acad Sci U S A (1994) 1.99

TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing. J Biol Chem (2008) 1.98

The SMN complex. Exp Cell Res (2004) 1.96

Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol (2007) 1.91

Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients. Brain (2009) 1.91

Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene (2005) 1.87

RNA translation in axons. Annu Rev Cell Dev Biol (2004) 1.87

Mutations in FUS cause FALS and SALS in French and French Canadian populations. Neurology (2009) 1.87

Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol (2008) 1.86

Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain (2008) 1.84

Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort. Neurology (2009) 1.83

The SMN complex: an assembly machine for RNPs. Cold Spring Harb Symp Quant Biol (2006) 1.79

Embryonic motor axon development in the severe SMA mouse. Hum Mol Genet (2008) 1.79

Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain (2008) 1.79

Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations. Arch Neurol (2008) 1.78

Identification and characterization of an angiogenin-binding DNA sequence that stimulates luciferase reporter gene expression. Biochemistry (2003) 1.78

Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo. Nucleic Acids Res (2009) 1.77

Articles by these authors

Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet (2009) 4.38

Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol (2010) 3.61

Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet (2009) 2.22

Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature (2012) 2.08

Genome-wide association analyses in Han Chinese identify two new susceptibility loci for amyotrophic lateral sclerosis. Nat Genet (2013) 1.57

Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration. Hum Mol Genet (2008) 1.46

Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann Neurol (2011) 1.45

Genome complexity reduction for SNP genotyping analysis. Proc Natl Acad Sci U S A (2002) 1.32

Paraoxonase gene mutations in amyotrophic lateral sclerosis. Ann Neurol (2010) 1.20

The role of copy number variation in susceptibility to amyotrophic lateral sclerosis: genome-wide association study and comparison with published loci. PLoS One (2009) 1.19

A simple, bead-based approach for multi-SNP molecular haplotyping. Nucleic Acids Res (2005) 1.11

Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy. Am J Hum Genet (2011) 1.09

Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1. Neurobiol Aging (2012) 1.02

A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. Hum Mol Genet (2013) 0.98

A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts. Neurobiol Aging (2012) 0.98

Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS. PLoS One (2012) 0.95

A large genome scan for rare CNVs in amyotrophic lateral sclerosis. Hum Mol Genet (2010) 0.92

Characterization of FUS mutations in amyotrophic lateral sclerosis using RNA-Seq. PLoS One (2013) 0.87

Genetic determinants of amyotrophic lateral sclerosis as therapeutic targets. CNS Neurol Disord Drug Targets (2010) 0.87

Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia. Neurobiol Aging (2012) 0.87

Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stress. Angiogenesis (2012) 0.85

C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis. Ann Neurol (2014) 0.83

Mutational analysis of TARDBP in neurodegenerative diseases. Neurobiol Aging (2009) 0.82

Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis. Neurobiol Aging (2013) 0.81

No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis. Hum Mol Genet (2013) 0.80

Prevalence of Huntington's disease gene CAG repeat alleles in sporadic amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler (2012) 0.77

Polymorphisms in the GluR2 gene are not associated with amyotrophic lateral sclerosis. Neurobiol Aging (2010) 0.76

TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations. J Neurol (2015) 0.75

High-throughput mutation screening using a single amplification condition. Methods Mol Biol (2009) 0.75